114 results
8-K
EX-2.1
CHRS
Coherus Biosciences Inc
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
and Benefits
Section 6.9
Sale or Disposal of Company Interests
Section 6.10
Reorganization
Section 6.11
Bulk Transfer Laws
Section 6.12
Termination … routine claims for benefits in the ordinary course of business, and (ii) none of the Benefit Plans is under audit, inquiry, proceeding, investigation
8-K/A
EX-99.1
g8iz2p
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
424B5
bxq7bpx
12 Sep 23
Prospectus supplement for primary offering
6:04am
8-K
EX-99.1
t8m6i0l
8 Sep 23
Coherus Completes Surface Oncology Acquisition
9:12am
424B3
u7j0uoob
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
239 t3g7scc9ed
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
5uchh jhoo1x
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
sbbu2
16 Jun 23
Business combination disclosure
5:17pm
425
7wvh4
16 Jun 23
Business combination disclosure
5:16pm
425
wjbbof
16 Jun 23
Business combination disclosure
5:14pm
425
zna 2kiey
16 Jun 23
Business combination disclosure
5:14pm
425
poivigpwpirlqe6d
16 Jun 23
Business combination disclosure
5:12pm
425
n2gke0
16 Jun 23
Business combination disclosure
5:11pm